EcoR1 Capital

EcoR1 Capital as of March 31, 2018

Portfolio Holdings for EcoR1 Capital

EcoR1 Capital holds 31 positions in its portfolio as reported in the March 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Assembly Biosciences 14.5 $145M 2.9M 49.14
Ascendis Pharma A S (ASND) 12.0 $119M 1.8M 65.40
Fibrogen (FGEN) 9.3 $93M 2.0M 46.20
Ironwood Pharmaceuticals (IRWD) 9.1 $91M 5.9M 15.43
Kura Oncology (KURA) 7.1 $71M 3.8M 18.75
Wave Life Sciences (WVE) 5.9 $59M 1.5M 40.10
Array BioPharma 5.0 $50M 3.0M 16.32
Dicerna Pharmaceuticals 4.6 $46M 4.8M 9.56
Macrogenics (MGNX) 3.7 $37M 1.5M 25.16
Arcus Biosciences Incorporated (RCUS) 3.5 $35M 2.2M 15.44
Celgene Corp option 3.4 $34M 385k 89.21
Apellis Pharmaceuticals (APLS) 2.3 $23M 1.1M 22.11
Five Prime Therapeutics 2.1 $21M 1.2M 17.18
Urogen Pharma (URGN) 2.0 $20M 402k 49.69
Fibrogen 1.5 $15M 325k 46.20
Immune Design 1.4 $14M 4.4M 3.25
Agios Pharmaceuticals (AGIO) 1.4 $14M 173k 81.78
Achillion Pharmaceuticals 1.4 $14M 3.7M 3.70
Akebia Therapeutics (AKBA) 1.4 $14M 1.4M 9.53
Dova Pharmaceuticals 1.2 $12M 430k 27.12
Atyr Pharma Inc Common Stock Usd 0.001 1.1 $11M 3.9M 2.70
Dbv Technologies S A 1.0 $10M 450k 23.07
Ironwood Pharmaceuticals Inc cl a 1.0 $10M 668k 15.43
Protagonist Therapeutics (PTGX) 0.9 $9.3M 1.1M 8.59
Synlogic 0.7 $6.6M 700k 9.38
Denali Therapeutics (DNLI) 0.6 $6.4M 325k 19.69
Rhythm Pharmaceuticals (RYTM) 0.6 $6.3M 319k 19.90
Corvus Pharmaceuticals (CRVS) 0.5 $5.4M 470k 11.53
Newlink Genetics 0.4 $4.1M 560k 7.25
Kindred Biosciences 0.2 $2.2M 249k 8.65
Geron Corporation (GERN) 0.1 $1.5M 350k 4.25